Vitamin D has been shown in studies to be a powerful inhibitor of retinal neovascularization and to reduce vascular endothelial growth factor (VEGF) production, indicating its role in the pathogenesis of diabetic retinopathy (Zhang et al. 2016). This evidence concerns the gene VEGFA and diabetic retinopathy.